Journal profile · Oncology

Wspolczesna Onkologia-Contemporary Oncology

ISSN 1428-2526 · eISSN 1897-4309 · Termedia Publishing House Ltd. · POLAND · Monthly · Founded 1997

Wspolczesna Onkologia-Contemporary Oncology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.3 (journal website); fully open access; APC charged, amount not published; median 59 days to acceptance (65 articles, last 24 months); community-reported acceptance: easy; 48 articles in 2025; indexed in ESCI and Scopus.

Impact factor1.3From the journal's website, latest value
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time59 daysMedian, submission to acceptance · 65 articles, last 24 months · PubMed
APCCharged, amount not publishedFully open access
AcceptanceEasyCommunity average
Articles per year482025 · OpenAlex count

Scope

Aims, scope and focus

Wspolczesna Onkologia-Contemporary Oncology is published by Termedia Publishing House Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Multiple and Secondary Primary Cancers, Lung Cancer Treatments and Mutations and Cancer survivorship and care, together about 16.9% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)

Contemporary Oncology is a journal aimed at oncologists, oncological surgeons, hematologists, radiologists, pathologists, radiotherapists, palliative care specialists, psychologists, nutritionists, and representatives of any other professions, whose interests are related to cancer. Manuscripts devoted to basic research in the field of oncology are also welcomed.

From the journal's Aims & Scope

Research area (LetPub): Oncology

Editorial board by country: none in mainland China; most named Poland 30, United States 9, Germany 3, Italy 3, United Kingdom 2 (54 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Multiple and Secondary Primary CancersMedicine6.2%
  2. Lung Cancer Treatments and MutationsMedicine5.6%
  3. Cancer survivorship and careMedicine5.1%
  4. Head and Neck Cancer StudiesMedicine4.8%
  5. Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology4.5%
  6. Lymphoma Diagnosis and TreatmentMedicine4.5%
  7. Inflammatory Biomarkers in Disease PrognosisMedicine4.4%
  8. Cancer Diagnosis and TreatmentMedicine4.3%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorOncologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorOncologyZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor (publisher)
1.3Publisher website ·
CiteScore 2026-06
2.4LetPub ·
SJR 2026-06
0.4LetPub ·
SNIP 2026-06
0.46LetPub ·
h-index
16LetPub ·
h-index
44OpenAlex ·
i10-index
296OpenAlex ·
2-year mean citedness
1.2OpenAlex ·
Self-citation rate
23.1%LetPub ·
Share of gold OA articles
98.45%LetPub ·

Volume

Articles per year
47LetPub ·

Articles by year OpenAlex count · 1,076 in total · the current year is incomplete

YearArticlesOpen accessCitations
202624244
2025484851
2024434383
20234040105
20224343293
202143431,145

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

59 daysMedian, submission to acceptance · P25–P75 42 days – 88 days

Acceptance to online
median 74 days (64 articles)
Submission to online
median 142 days
Sample
65 articles with submission and acceptance dates (70 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
4–8 weeksLetPub ·
Average acceptance (community reports)
EasyLetPub ·
Submission to acceptance
7 daysPublisher website ·
Submission to publication (journal-reported)
about 24 weeksDOAJ ·
Peer review
Double anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJPLN 1,650 / EUR 350NoCC BY-NC-SA
OpenAlexEUR 200——
LetPubEUR 200No—
Publisher websiteYes, amount not published——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare6 items from the author guidelines
Abstract
200–250 words
Keywords
≥ 4
Manuscript length
≤ 3,000 words
Reference style
Numbered, in order of citation
First submission
Free format: the journal's layout is not required
Graphical abstract
Required
Publisher website · model-extracted, each line checked against the text
Article types accepted10, with length limits
  1. case reportCase report Reirradiation and teclistamab in relapsed multiple myeloma: initial experience in two heavily pretreated patients with extensive diseaseLength not stated
  2. case reportsContemporary Oncology/Współczesna Onkologia is a scientific and educational, peer-reviewed, bimonthly journal which publishes Original papers on experimental an…Length not stated
  3. editorialsEditorials are written on invitation.Length not stated
  4. letterructured abstract of up to 150 words. • Letters to Editors may include up to 1000 words and 10 references. Do not include abstract nor subheadings.main text ≤ 1,000 words
  5. letters to editorsLetters to Editors may include up to 1000 words and 10 references.Length not stated
  6. original paperOriginal paper Fibroblast growth factor receptor 1 status discordance between primary breast tumours and lymph node metastases is associated with peripheral blo…Length not stated
  7. original papersOriginal papers should be structured in the following order: Introduction, Material and methods, Results, Discussion, References.Length not stated
  8. reviewManuscripts submitted to the Editorial Office are assessed by reviewers. The rules of review are in conformity with the guidelines of the Ministry of Science an…Length not stated
  9. review paperReview paper Clinical guidelines for the management of cytostatic extravasation in childrenLength not stated
  10. review papersReviews may have free-form layout.Length not stated
Publisher website
Policy excerpts from the journal's websiteConflicts of interest, Publication ethics, Open access, Peer review, Plagiarism, Trial registration / reporting guidelines
Conflicts of interest Conflict of interest

Conflict of interest Model summary

Authors are expected to describe sources of the research founding, a role of potential sponsor in planning, executing and analysis of the study, and the influence (bias) the funding organization had on the content of the article. Other relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony) providing potential sources of conflict of interest in relation…

Source ↗Publisher website ·
Publication ethics

ICMJE policies Model summary

Contemporary Oncology is published in accordance with ICMJE policies and recommendations.

Source ↗Publisher website ·
Open access

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications Model summary

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Source ↗Publisher website ·
Peer review Review process

Double-blinded peer review Model summary

Manuscripts submitted to the Editorial Office are assessed by reviewers. The rules of review are in conformity with the guidelines of the Ministry of Science and Higher Education (www.nauka.gov.pl). The Contemporary Oncology/Współczesna Onkologia has always used a double-blinded peer review process. The Editorial Office verifies that the submitted manuscript complies with the journal’s formal requ…

Source ↗Publisher website ·
Plagiarism

Plagiarism policy Model summary

The Contemporary Oncology/Współczesna Onkologia will not tolerate plagiarism in any form.

Source ↗Publisher website ·
Trial registration / reporting guidelines

Clinical trial registration Model summary

The ICMJE requires - and recommends that all medical journal editors require - registration of clinical trials in a public trials registry at or before the time of first patient enrollment as a condition of consideration for article publication.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Termedia Publishing House Ltd.
Country or region
POLAND
Language
English
Frequency
Monthly
Founded
1997
ISSN
1428-2526
Electronic ISSN
1897-4309
Latest issue on the website
Volume 30 (2026)
Official links

FAQ

Frequently asked questions about Wspolczesna Onkologia-Contemporary Oncology

What CAS zone is Wspolczesna Onkologia-Contemporary Oncology in?

In the 2025 upgraded edition of the CAS Journal Ranking, Wspolczesna Onkologia-Contemporary Oncology is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Wspolczesna Onkologia-Contemporary Oncology?

The journal's website gives an impact factor of 1.3; this is the journal's own figure, as LetPub lists none for it; CiteScore 2.4, h-index 44.

How long does peer review take at Wspolczesna Onkologia-Contemporary Oncology?

Based on the dates recorded on 65 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 59 days (interquartile range 42–88 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Wspolczesna Onkologia-Contemporary Oncology?

According to the journal's author guidelines: Abstract: 200–250 words; Keywords: ≥ 4; Manuscript length: ≤ 3,000 words; Reference style: Numbered, in order of citation; First submission: Free format: the journal's layout is not required; Graphical abstract: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of Wspolczesna Onkologia-Contemporary Oncology based?

Of the 54 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Poland (30), United States (9) and Germany (3). Counted from the institutions listed on the board page; for reference only.

Which databases index Wspolczesna Onkologia-Contemporary Oncology?

According to LetPub and DOAJ records, Wspolczesna Onkologia-Contemporary Oncology is indexed in ESCI, Scopus and DOAJ.

Is Wspolczesna Onkologia-Contemporary Oncology open access, and what is the APC?

Wspolczesna Onkologia-Contemporary Oncology is a fully open-access journal. APC charged, amount not published.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .